Corient Capital Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | $1.56M | Buy |
25,218
+1,705
| +7% | +$105K | 0.12% | 156 |
|
2022
Q2 | $1.45M | Buy |
23,513
+4,917
| +26% | +$304K | 0.11% | 168 |
|
2022
Q1 | $1.11M | Sell |
18,596
-1,003
| -5% | -$59.7K | 0.07% | 230 |
|
2021
Q4 | $1.42M | Buy |
19,599
+465
| +2% | +$33.8K | 0.09% | 190 |
|
2021
Q3 | $1.34M | Buy |
19,134
+129
| +0.7% | +$9.01K | 0.1% | 193 |
|
2021
Q2 | $1.31M | Buy |
19,005
+1,761
| +10% | +$121K | 0.1% | 189 |
|
2021
Q1 | $1.12M | Buy |
17,244
+5,865
| +52% | +$379K | 0.1% | 188 |
|
2020
Q4 | $663K | Sell |
11,379
-4,064
| -26% | -$237K | 0.07% | 231 |
|
2020
Q3 | $976K | Sell |
15,443
-4,921
| -24% | -$311K | 0.11% | 168 |
|
2020
Q2 | $1.57M | Buy |
20,364
+5,869
| +40% | +$452K | 0.19% | 110 |
|
2020
Q1 | $1.08M | Buy |
14,495
+3,132
| +28% | +$234K | 0.17% | 117 |
|
2019
Q4 | $739K | Buy |
11,363
+839
| +8% | +$54.6K | 0.09% | 222 |
|
2019
Q3 | $667K | Sell |
10,524
-405
| -4% | -$25.7K | 0.09% | 218 |
|
2019
Q2 | $738K | Buy |
10,929
+3,683
| +51% | +$249K | 0.11% | 187 |
|
2019
Q1 | $471K | Sell |
7,246
-22,726
| -76% | -$1.48M | 0.08% | 230 |
|
2018
Q4 | $1.88M | Sell |
29,972
-12,054
| -29% | -$754K | 0.33% | 86 |
|
2018
Q3 | $3.25M | Hold |
42,026
| – | – | 0.54% | 43 |
|
2018
Q2 | $2.98M | Buy |
42,026
+5,877
| +16% | +$416K | 0.52% | 45 |
|
2018
Q1 | $2.73M | Buy |
36,149
+16,708
| +86% | +$1.26M | 0.5% | 51 |
|
2017
Q4 | $1.39M | Sell |
19,441
-14,421
| -43% | -$1.03M | 0.24% | 103 |
|
2017
Q3 | $2.74M | Sell |
33,862
-10,064
| -23% | -$816K | 0.52% | 47 |
|
2017
Q2 | $3.11M | Sell |
43,926
-645
| -1% | -$45.7K | 0.48% | 53 |
|
2017
Q1 | $3.03M | Sell |
44,571
-661
| -1% | -$44.9K | 0.47% | 47 |
|
2016
Q4 | $3.24M | Buy |
45,232
+15,005
| +50% | +$1.07M | 0.57% | 39 |
|
2016
Q3 | $2.39M | Buy |
+30,227
| New | +$2.39M | 0.44% | 49 |
|